BetaShares Legg Mason Equity Income Fund logo

BetaShares Legg Mason Equity Income Fund (EINC)

Market Closed
ASX ASX
- Market Cap
0.23% Div Yield
32,423 Volume
Want to track EINC and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

EINC pays dividends to its shareholders, with the most recent payment made on Oct 16, 2024. The next estimated payment will be in 16 Oct 2024 on Oct 16, 2024 for a total of A$0.00094.
The stock of the company had never split.
The company's stock is traded on one exchange.

BetaShares Legg Mason Equity Income Fund (EINC) FAQ

On which exchange is it traded?

BetaShares Legg Mason Equity Income Fund is listed on ASX.

What is its stock symbol?

The ticker symbol is EINC.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.23%.

What is its market cap?

As of today, no market cap data is available.

Has BetaShares Legg Mason Equity Income Fund ever had a stock split?

No, there has never been a stock split.

BetaShares Legg Mason Equity Income Fund Profile

ASX Exchange
GB Country

Overview

ConvaTec Group PLC is a global entity specializing in the innovation, production, and marketing of medical products, services, and technologies. The company operates across Europe, North America, and other international markets. It focuses on offering solutions for the management of acute and chronic wounds, ostomy care, continence care, critical care, and infusion care needs. Founded in 1978, ConvaTec is dedicated to enhancing the lives of people with medical conditions that require specialized care, by providing advanced medical products. Headquartered in London, United Kingdom, the company reaches its customers through direct sales and a network of distributors and wholesalers, catering to pharmacies, hospitals, and a variety of healthcare providers.

Products and Services

  • Advanced Wound Dressings and Skin Care Products:

    These products are designed for the management of acute and chronic wounds caused by conditions such as diabetes, as well as wounds resulting from traumatic injuries and burns. They support the healing process, offering solutions for both healthcare providers and patients managing wound care.

  • Ostomy Care Solutions:

    ConvaTec provides a comprehensive range of devices, accessories, and services for individuals with a stoma, which may be due to colorectal cancer, inflammatory bowel disease, or bladder cancer. These solutions aim to improve the quality of life for people living with a stoma by addressing their specific needs.

  • Continence Care Products and Services:

    Targeting individuals with urinary continence issues stemming from spinal cord injuries, multiple sclerosis, spina bifida, and other causes, these products and services offer support and solutions to manage continence, enhancing the users' independence and confidence.

  • Critical Care Devices and Products:

    These are utilized in intensive care units and hospital settings, offering essential support for critically ill patients. ConvaTec’s critical care range includes devices and products that cater to the specific needs of patients requiring intensive medical attention.

  • Infusion Care Solutions:

    Comprising disposable infusion sets designed either for insulin pumps used by diabetes patients or for pumps facilitating continuous subcutaneous infusion treatments for conditions like Parkinson’s disease, these solutions demonstrate ConvaTec’s commitment to improving the management of chronic conditions through innovation.

Contact Information

Address: 20 Eastbourne Terrace
Phone: 44 11 8952 8100